Alessandro Rodolico

Associate Professor
Psychiatry - MEDS-11/A

Alessandro Rodolico is a psychiatrist with a PhD in Neuroscience. He trained at the University of Catania, where he obtained his medical degree and completed specialist training in Psychiatry. He also trained in transactional analysis psychotherapy at PerFormat. From 2022 to 2023, he worked as a psychiatrist at the “G. Rodolico–San Marco” University Hospital in Catania, where he led outpatient services for pharmacovigilance and adverse-effect screening and for the psychopathological assessment of bariatric surgery candidates. In 2025, he obtained the Italian National Scientific Qualification for Associate Professor in Psychiatry.

He is Associate Professor of Psychiatry at UniCamillus – Saint Camillus International University of Health Sciences and collaborates with Professor Stefan Leucht’s group at the Technical University of Munich, where he undertook part of his training and worked as a researcher. His research focuses on systematic reviews and meta-analyses of pharmacological and psychosocial treatments in psychiatry, with particular emphasis on schizophrenia, antipsychotic tolerability and shared decision-making.

He served as a sub-investigator in the SUSTAIN-1 study of esketamine (2016–2017) and the RELIEVE study (2018–2020), and as a co-investigator in VESPA, an independent multicentre trial funded by the Italian Medicines Agency (AIFA) comparing vortioxetine with SSRIs in late-life depression (2018–2023). He coordinates SHADE-S, a multicentre observational study of decision-making styles in outpatients with psychosis, and contributes to the development of STEP-SE and the Shared Decision Making Assistant (SDMA), tools for assessing adverse effects and supporting shared decisions about antipsychotic treatment.

He is interested in artificial intelligence and the automation of research workflows, with a focus on approaches that support researchers in synthesising and appraising scientific evidence. He has authored and coauthored publications in international journals including The Lancet, The Lancet Psychiatry and the Cochrane Database of Systematic Reviews.